Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Investigating the sweet side of gonorrhea to understand nutrient acquisition and sugar-based interactions with the host

Award Number: R01AI184894
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/15/2025
PERIOD OF PERFORMANCE END DATE: 08/31/2030

Group Awards By:

View Award Description

Investigating the sweet side of gonorrhea to understand nutrient acquisition and sugar-based interactions with the host - The human-specific pathogen Neisseria gonorrhoeae (Ngo) causes the common sexually transmitted infection gonorrhea. Rapid evolution of drug resistance by Ngo has led to its identification as an urgent threat and emphasizes the need to identify an efficacious vaccine or more effective treatments. Our strategy to develop better therapeutics has focused on conserved outer membrane transport proteins that provide critical growth supporting functions during human infection. The outer membrane transport system (TbpA/B) that enables Ngo to employ human transferrin as an iron source is necessary for and produced during human infections. The highly conserved zinc transporters (TdfH and TdfJ) are also expressed in vivo. Potential drugs that target these receptors are expected to starve the bacteria of these essential nutrients. While the human protein ligands for these transport systems are known, we unexpectedly observed that these transporters also bind to distinct glycan moieties. Although transferrin is indeed glycosylated, the ligands for the zinc transporters, human calprotectin and human S100A7, are not glycan modified. This unanticipated observation led us to consider the novel concept that the outer membrane transporters serve other functions, potentially interacting with host cell glycan-modified proteins, in addition to enabling Ngo to overcome nutritional immunity. In this application, we propose interrogate the transporter-glycan interactions and assess whether these interactions are possibly “druggable”. We hypothesize that these TonB-dependent transporters (TdTs) serve additional host-specific functions (e.g., support nutrient transport or facilitate association with host cells) and that interference of TdT-glycan interactions will block Ngo infection of host cells. These studies are significant because identification of novel compounds to interfere with either nutrient acquisition or host cell interactions could lead to new insights into therapeutic interventions for an urgent threat pathogen that is close to being impossible to treat with existing drugs. These studies are innovative because our unexpected observation that the gonococcal outer membrane transporters also bind to distinct sugar residues raises the innovative possibility that these proteins are multi-functional and serve important functions in the context of host cell interaction, in addition to their known functions in nutrient acquisition. Other innovative aspects include the assembled team, the complementary approaches to be utilized, and the panel of unique reagents including monoclonal antibodies and drugs that could block critical TdT-dependent virulence functions including host cell interaction and nutrient acquisition. The specific aims of this new proposal are as follows. Aim 1: Determine the glycans/ligands that the TdTs interact with on host cells. Aim 2: Characterize the molecular details that define the TdT-glycan interactions. Aim 3: Investigate the ability of antibodies and compounds to block TdT-glycan interactions and TdT functions. Overall, these innovative studies will thoroughly interrogate the newly-recognized TdT-glycan interactions with a focus on interfering with key virulence characteristics contributed by these well conserved outer membrane transport systems.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $684,868 )
2026	2026	GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC	58 EDGEWOOD AVE NE	ATLANTA	GA	30303	FULTON	USA	Allergy and Infectious Diseases Research	001	2	9/16/2026	SUPPLEMENT FOR EXPANSION	$227,601
2026	2026	GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC	58 EDGEWOOD AVE NE	ATLANTA	GA	30303	FULTON	USA	Allergy and Infectious Diseases Research	000	2	9/3/2026	NON-COMPETING CONTINUATION	$457,267
														Subtotal = $684,868

Issue Date FY: 2025 ( Subtotal = $684,627 )
2025	2025	GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC	58 EDGEWOOD AVE NE	ATLANTA	GA	30303	FULTON	USA	Allergy and Infectious Diseases Research	000	1	9/15/2025	NEW	$457,026
2025	2025	GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC	58 EDGEWOOD AVE NE	ATLANTA	GA	30303	FULTON	USA	Allergy and Infectious Diseases Research	001	1	9/17/2025	SUPPLEMENT FOR EXPANSION	$227,601
														Subtotal = $684,627

Grand Total All Awards = $1,369,495

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigating the sweet side of gonorrhea to understand nutrient acquisition and sugar-based interactions with the host

Award Number: R01AI184894

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/15/2025

PERIOD OF PERFORMANCE END DATE: 08/31/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer